Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daryl S Walter

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptorPaul J Beswick, Andy Billinton, Laura J Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptorLaura J Chambers, Alexander J Stevens, Andrew P Moses, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptorLee Abberley, Aude Bebius, Paul J Beswick, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2009
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituentNicolas Charrier, Brian Clarke, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296Brian Clarke, Leanne Cutler, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2009
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimeticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2009
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokineticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Journal of Medicinal Chemistry|May 7, 2008
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailabilityNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs)Brian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptorPaul J Beswick, Andy Billinton, Laura J Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptorLaura J Chambers, Alexander J Stevens, Andrew P Moses, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptorLee Abberley, Aude Bebius, Paul J Beswick, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2009
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituentNicolas Charrier, Brian Clarke, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296Brian Clarke, Leanne Cutler, Emmanuel Demont, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2009
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimeticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2009
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokineticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Journal of Medicinal Chemistry|May 7, 2008
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailabilityNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs)Brian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Emmanuel Demont, Colin Dingwall, et al.
Pageof 3